Afluria

**Afluria** is a Seqirus seasonal, egg-based, inactivated split-virion influenza vaccine for active immunization against influenza disease caused by the influenza A subtypes and influenza B virus strains represented in the season-specific formulation. It is administered intramuscularly and induces strain-specific humoral immune responses, principally antibodies to influenza viral hemagglutinin, which can neutralize circulating influenza viruses and reduce influenza disease risk. The FDA lists Afluria as an approved influenza vaccine for individuals aged 6 months and older; its formulations and included strains are updated by season. ([fda.gov](https://www.fda.gov/vaccines-blood-biologics/vaccines/afluria-afluria-southern-hemisphere))

Brand names

Afluria

Other names

AfluriaFluvaxNilgripInactivated Influenza Vaccine